CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR

Stock Information for CytoSorbents Corporation

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About CytoSorbents Corporation

CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights
In Memoriam: Dr. Robert Hawes Bartlett (1939-2025) - Father of Extracorporeal Membrane Oxygenation (ECMO) and Former CytoSorbents Chief Medical Officer
CytoSorbents to Showcase Pioneering New Cardiac Surgery Data in Key Applications at the EACTS 2025 Annual Meeting in Copenhagen
CytoSorbents Provides DrugSorb-ATR Regulatory Update
CytoSorbents To Host Global Webinar on "Turning the Tide in Sepsis and Septic Shock: Real World Insights with CytoSorb" in Recognition of World Sepsis Day
CytoSorbents to Present at the H.C. Wainwright 27th Annual Global Investment Conference
CytoSorbents Reports Second Quarter 2025 Financial Results and Provides Business Update
CytoSorbents Leads a New Era in Sepsis Treatment

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.